As the global economy mends, the 2021 growth of Cefazolin Sodium for Injection will have significant change from previous year. According to our researcher latest study, the global Cefazolin Sodium for Injection market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Cefazolin Sodium for Injection market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.

The United States Cefazolin Sodium for Injection market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Cefazolin Sodium for Injection market, reaching US$ million by the year 2028. As for the Europe Cefazolin Sodium for Injection landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.

Global main Cefazolin Sodium for Injection players cover Shanxi PUDE Pharmaceutical, QILU Pharmaceutical, Cspc Heibei Zhongrun Pharmaceutiacl, and ZheJiang JuTai Pharmaceutical, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Cefazolin Sodium for Injection market by product type, application, key manufacturers and key regions and countries.

Segmentation by specification: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

0.5g/Piece (Calculated As Cefazolin Sodium)

1.0g/Piece (Calculated As Cefazolin Sodium)

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Hospital Pharmacy

Retail Pharmacy

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Shanxi PUDE Pharmaceutical

QILU Pharmaceutical

Cspc Heibei Zhongrun Pharmaceutiacl

ZheJiang JuTai Pharmaceutical

Reyoung Pharmaceutical

Tongfang Pharmaceutical

Youcare Pharmaceutical

Beijing Taiyang Pharmaceutical

Anhui Hongye Pharmaceutical

Haikou Qili Pharmaceutical

Hunan Kelun Pharmaceutical